The global ELISA analyzers market is poised for significant growth, projected to reach $960.7 million by 2031, driven by technological advancements, increasing demand for sophisticated diagnostic tools, and a rising prevalence of chronic diseases. This report provides a comprehensive analysis of the market’s key drivers, trends, segmentation, and leading players.